Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kinnate Biopharma Inc.

    NASDAQ: KNTE · Real-Time Price · USD
    2.65
    -0.01 (-0.38%)
    At close: Apr 02, 2024, 10:00 PM

    Kinnate Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 57M 29.26M 116.1M
    Short-Term Investments
    		 97.04M 172.21M 103.36M
    Long-Term Investments
    		 10.63M 39.14M 105.45M
    Other Long-Term Assets
    		 38K 2.4M 1.77M
    Receivables
    		 n/a n/a n/a
    Inventory
    		 n/a n/a n/a
    Other Current Assets
    		 4.14M 3.64M 5.64M
    Total Current Assets
    		 158.18M 230.84M 258.69M
    Property-Plant & Equipment
    		 4.76M 6.45M 956K
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 15.43M 47.99M 108.17M
    Total Assets
    		 173.6M 278.83M 366.86M
    Account Payables
    		 2.03M 2.97M 3.15M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 892K 991K n/a
    Other Current Liabilities
    		 9.07M 13.21M 9.24M
    Total Current Liabilities
    		 11.99M 17.17M 12.39M
    Long-Term Debt
    		 2.28M 3.19M n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a
    Total Long-Term Liabilities
    		 2.28M 3.19M 35M
    Total Liabilities
    		 14.28M 20.36M 12.39M
    Total Debt
    		 3.17M 4.18M n/a
    Common Stock
    		 5K 4K 4K
    Retained Earnings
    		 -372.01M -259.36M -143.09M
    Comprehensive Income
    		 -12K -1.41M -524K
    Shareholders Equity
    		 159.33M 223.47M 319.48M
    Total Investments
    		 107.67M 211.35M 208.81M

    Add to Watchlist